Steven Cohen’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

Steven Cohen’s Portfolio MYOK Stock Details MYOK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-8,401	Closed	-$812K	–	1176
2020 Q2	$812K	Buy	+8,401	New	+$701K	0.01%	683
2017 Q2	–	Sell	-117,537	Closed	-$1.55M	–	1066
2017 Q1	$1.55M	Buy	+117,537	New	+$1.51M	0.01%	699

Other funds holding MYOK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Steven Cohen's MYOK Position: Q3 2020 in Review

Steven Cohen sold out of MyoKardia, Inc. Common Stock (MYOK) in Q3 2020, closing a stake of 8,401 shares — an estimated $812K sold.

Steven Cohen first reported a position in MYOK in Q1 2017 and held it in 2 quarters. The position peaked at $1.55M in Q1 2017. 237 funds tracked by Wall St. Rank hold MYOK as of Q3 2020.

Steven Cohen reported no remaining MyoKardia, Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
Steven Cohen sold 8,401 MyoKardia, Inc. Common Stock shares in Q3 2020, an estimated $812K.
Steven Cohen first reported a position in MyoKardia, Inc. Common Stock in Q1 2017 and held it in 2 quarters.
Steven Cohen's MyoKardia, Inc. Common Stock position peaked at $1.55M in Q1 2017.
237 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q3 2020.

Based on Point72 Asset Management's 13F filing for Q3 2020, filed 16 Nov 2020.